Tourette’s Syndrome: diagnostic and therapeutic algorithms to improve patient's quality of life
- M. Porta MD - D. Servello MD
IRCCS Galeazzi - Milano Tourette Center 20-21/09/2010 Warsaw
and therapeutic algorithms to improve patient's quality of life M. - - PowerPoint PPT Presentation
Tourettes Syndrome: diagnostic and therapeutic algorithms to improve patient's quality of life M. Porta MD - D. Servello MD IRCCS Galeazzi - Milano Tourette Center 20-21/09/2010 Warsaw Definite Tourette Syndrome (The Tourette Syndrome
IRCCS Galeazzi - Milano Tourette Center 20-21/09/2010 Warsaw
Definite Tourette Syndrome
(The Tourette Syndrome Classification Study Group)
some time during the illness, although not necessarily concurrently
throughout a period of more than 1 year
medical conditions
directly at some point in the illness or be recorded by videotape or cinematography (Definite Tourette Syndrome)
and description of tics as demonstrated must be accepted by reliable examiner (Tourette Syndrome by History)
Jankovic classification of tics and movements
NOSI, SIB, OCB: have to be included in the syndrome
Robertson - Baron Cohen: TS simple TS full blown TS plus
GTS-QOL inventory
VOLUNTARY
SEMIVOLUNTARY (UNVOLUNTARY)
INVOLUNTARY
AUTOMATIC
(Jankovic)
TIC TIC TIC
Robertson – Cohen classification of TS
Simple motor/vocal Tics Complex phonic Tics (copro-, eco-, pali- lalia/praxia) Hypermotricity/attention deficit,
psychic disorders, SIB, NOSI, etc..
Classification of Tics
(Jankovic)
Simple motor tics: Tonic (< 100ms) Distonic (>300 ms) Clonic (>500ms) Complex Motor Tics: Seemingly nonpurposeful Seemingly purposeful Simple Phonic Tics Complex Phonic Tics Ideic Tics
Comorbidity – Morbidity in TS (plus)
Porta and Servello, 2007 M M Robertson, 2000; Freeman et al, 2000
sensations before TICS
involvement of the central integration?
Comments
(VIDEO)
Conditions not to be confused:
single gene has been convincingly idientified
incomplete penetrance)
Etiological hypotheses
Neuroanatomic hypothesis: striatum abnormality (alterated synaptogenesis) Neurophysiological hypothesis: thalamic afferents disinhibition, blockade of cortical inhibitions Neurochemical hypothesis: dopaminergic hypersensitivity, presinaptic abnormality, second mediator abnormality
Genetics Neuro-biology: GABA, glutammate, 5-HT, dopamine, neuroendocrine factors Phenotypes of TS
Environmental
ganglia
component of motor system; evidence that basal ganglia interact with all of the frontal cortex and with limbic system …” J.V. Mink
combination of alterated movements, affective and cognitive disorders …..
Comments
Comments
Impairment with personal distress, and comprimised quality of life of the family involving often colleagues, caregivers etc. (GTS-QOL inventory)
Comments
Natural history of disease
EXACERBATED POSSIBLE REMISSION
ATTENTION DEFICIT – HYPERACTIVITY DISORDER (ADHD)
MOTOR TICS with rostro – caudal progression PHONIC TICS (simple - complex)
OBSESSIVE – COMPULSIVE DISORDER (OCD)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 AGE (YEARS)
due to:
abnormal behaviour (part of TS)
neuropsychiatric conditions (cervical dystonia, hemifacial spasm progressive supranuclear palsy,etc.)
Items of the 5-domain GTS-QOL inventory from Schrag, 2007
PHYSICAL DOMAIN PSYCHOLOGICAL DOMAIN SOCIAL/ FAMILY DOMAIN WORK/ ECONOMIC DOMAIN COGNITIVE DOMAIN
MOVEMENT DISCONTROL ANXIETY DIFFICULTY IN FRIENDSHIPS FINANCIAL PROBLEMS MEMORY DEFICIT PHONIC TICS RESTLESSNESS NO SOCIAL ACTIVITIES NO JOB DIFFICULTY IN FINISHING TASKS PAIN OF INJURES DUE TO TICS MOOD SWITCHES UPSET BY PEOPLE SCHOOL/WORK PROBLEMS LOSING IMPORTANT THINGS EMBARASSING GESTURES LACK OF CONTROL EMBARRASS MENT NO CONCENTRATION INVOLUNTARY SWEARING DEPRESSED MOOD DIFFICULTY IN TALKING ABOUT ILLNESS ECOLALIA ECOPRASSIA SLEEP PROBLEMS LACK OF SELF CONFIDENCE PROBLEMS WITH AUTHORITIES SELF-HARM SEXUAL DIFFICULTIES FAMILIAR MATTERS
measure in TS
generic HR-QOL (QOLAS and SF.36)
Not completly assested Majority of available drugs without specific claim ! Health Economics problems (cost-utility)
At least 2 years of psychological therapy At least 2 of the following drugs:
Traditional and/or innovative antipsychotics Cathecolamines depletors SSRI
Inadequate clinical response and/or side effects
Treatment justified to improve social impairment (algorytm)
Observation Conservative treatment Mini invasive therapy
(Btx – DBS – etc.)
TS conservative therapy
Tic-oriented medications
ADHD-oriented medications
OCB-oriented medications
Psichotherapy
(Habit-Reversal promising)
Significant social impairment, self-inflicted or TS linked lesions, relevant drug side-effects Mild-to-moderate social impairment, not-satisfying response to drugs (refractory), self-motivation Minimal social impairment, satisfying drug response, not yet attempted, or possible conservative treatment, not defined chronic disease
Significant Tic Related Injuries
CM/pf / VOA Accumbens Pallidum: Anterior, Posterior, External PPN STN
Vo-CM/Pf DBS target
line
midpoint
Social impairment evaluation (GTS-QOL) Therapeutic algorythm Etiology of TS? Clinical fluctuations
Evaluation timing Spontaneous remission? Different targets reported Age at DBS? DBS: add-on or “second choice therapy”? Stimulating parameters regulation DBS candidates (refractory)
behavioral symptoms
personalized (also for DBS)
evaluated (health-related outcome: GTS-QOL)